Why is vaccination against Mycoplasma gallisepticum (MG) via eye-drop or spray superior to water administration in brown layers?

Mycoplasma gallisepticum (MG) is a highly destructive, cell-wall-less bacterium that colonizes the mucosal linings of the trachea and air sacs, causing chronic respiratory disease (CRD), pale shells, and severe egg drops. To protect flocks, live vaccines (such as the TS-11 or F-strain) are administered. While drinking water vaccination is easy and low-labor, it is highly ineffective for Mycoplasma. MG is a respiratory pathogen, and protection relies entirely on local mucosal immunity (secretory IgA antibodies) in the respiratory tract. When a live MG vaccine is delivered via eye-drop (intraocular) or coarse spray, the vaccine strains land directly on the conjunctiva and upper respiratory mucosa. This local contact stimulates the Harderian gland and local lymphoid tissue to produce high levels of mucosal IgA. These antibodies physically block wild-type field strains from attaching to tracheal epithelial cells. Water administration fails to stimulate this local respiratory barrier, leaving the birds susceptible. Farmers can study respiratory immunology in the Poultry Encyclopedia, buy cold-chain certified MG vaccines on Poultry Plaza, monitor daily egg prices on Poultry Rates, and trade on Murghi Mandi.